Skip to content

Safety and efficacy of afentanil in painless hysteroscopy

Safety and efficacy of afentanil in painless hysteroscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071060
Enrollment
Unknown
Registered
2023-05-04
Start date
2023-05-04
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine cavity disease

Interventions

Sponsors

The Third Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Patients requiring hysteroscopy in our hospital during the study period; 2)ASA classification: ?-?; 3) Age: 18-65 years old; 4)BMI: 18-30 kg/m 2; 5) Join the study voluntarily and sign the informed consent; 6) Non-allergic constitution; 7) Normal cognitive function; 8) Did not participate in clinical trials of other drugs 3 months before screening.

Exclusion criteria

Exclusion criteria: 1) Combined with other vital organ dysfunction: including severe liver and kidney function abnormalities, organic brain diseases, NYHA??, abnormal coagulation function; Sick sinus syndrome, bradycardia (HR< 55 times /min), atrioventricular block above degree ?; 2) Severe hypertension or diabetes; 3) Recent history of upper respiratory tract infection; 4) History of mental illness; 5) Other patients deemed unsuitable for inclusion by the investigator.

Design outcomes

Primary

MeasureTime frame
Incidence of Respiratory Depression;

Secondary

MeasureTime frame
drug dose;Subjective Satisfaction;

Countries

China

Contacts

Public ContactShaoliZhou

The Third Affiliated Hospital of Sun Yat-sen University

13610272308@139.com+86 13610272308

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026